Clinical Trials Browser

Phase 2 × Not yet recruiting × Small Cell Lung Cancer Extensive Stage × Clear all

NCT07022301 2025-06-15

Sintilimab Plus Anlotinib as Second or Further-line Therapy for ES-SCLC Who Have Progressed After Anti-PD-1/L1 Therapy

Phase 2 Not yet recruiting

Small Cell Lung Cancer Extensive Stage

NCT06851819 2025-02-28

TERE

Phase 2 Not yet recruiting

Small Cell Lung Cancer Extensive Stage